De Candia, Erica
 Distribuzione geografica
Continente #
NA - Nord America 2.053
EU - Europa 2.031
AS - Asia 886
SA - Sud America 165
AF - Africa 17
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.169
Nazione #
US - Stati Uniti d'America 2.023
DE - Germania 380
SE - Svezia 371
PL - Polonia 366
CN - Cina 301
IT - Italia 294
SG - Singapore 284
BR - Brasile 155
UA - Ucraina 136
IE - Irlanda 118
FR - Francia 100
GB - Regno Unito 76
IN - India 74
ID - Indonesia 72
FI - Finlandia 54
RU - Federazione Russa 42
HK - Hong Kong 23
TR - Turchia 20
BE - Belgio 19
IR - Iran 18
JP - Giappone 18
AT - Austria 17
KR - Corea 16
CA - Canada 15
NL - Olanda 14
AU - Australia 13
MX - Messico 13
VN - Vietnam 12
HU - Ungheria 11
IQ - Iraq 8
PK - Pakistan 7
CH - Svizzera 6
MY - Malesia 6
RO - Romania 6
ES - Italia 5
IL - Israele 5
AR - Argentina 4
EG - Egitto 4
MK - Macedonia 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
LT - Lituania 3
MA - Marocco 3
ZA - Sudafrica 3
EC - Ecuador 2
GE - Georgia 2
JO - Giordania 2
KE - Kenya 2
MN - Mongolia 2
PH - Filippine 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BZ - Belize 1
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.169
Città #
Warsaw 363
Chandler 333
Ashburn 205
Singapore 171
Dublin 113
Fairfield 106
San Mateo 90
Wilmington 85
Jakarta 70
Jacksonville 66
Woodbridge 62
Rome 61
Ann Arbor 59
Nanjing 59
Seattle 48
Boston 45
Houston 45
Marseille 42
Los Angeles 41
New York 37
Princeton 36
Beijing 35
Boardman 34
Milan 34
Moscow 34
Dearborn 33
Cambridge 28
Cattolica 28
Redwood City 28
Munich 23
Hefei 22
Hong Kong 22
Hyderabad 21
Lawrence 20
Chicago 18
Nanchang 18
The Dalles 17
Brussels 16
Nuremberg 16
Seoul 16
Helsinki 15
Hangzhou 13
London 13
Redmond 13
Andover 12
Augusta 12
Nürnberg 12
Pune 12
Izmir 11
Norwalk 11
Bremen 10
Budapest 10
Mountain View 10
San Diego 10
São Paulo 10
Vienna 10
Zhengzhou 10
Frankfurt am Main 9
Bari 8
Hebei 8
Washington 8
Buffalo 7
Düsseldorf 7
Guangzhou 7
Kunming 7
North Bergen 7
San Jose 7
Shenyang 7
Turku 7
University Park 7
Changsha 6
Cuauhtémoc 6
Florence 6
Kish 6
Putrajaya 6
Tokyo 6
Ypsilanti 6
Belo Horizonte 5
Dong Ket 5
Guarulhos 5
Kocaeli 5
Naples 5
Ottawa 5
Rio de Janeiro 5
Salvador 5
Sydney 5
Toronto 5
Busto Arsizio 4
Hanoi 4
Jiaxing 4
Jinan 4
Lappeenranta 4
Leawood 4
Perugia 4
Prilep 4
Shanghai 4
Tustin 4
Abidjan 3
Acton 3
Atlanta 3
Totale 3.031
Nome #
Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients 291
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 231
Eltrombopag for the treatment of inherited thrombocytopenias: a phase 2 clinical trial 166
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study 152
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) 141
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 136
Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. 135
Data on the application of early coagulation support protocol in the management of major trauma patients 126
Effect of fibrinogen concentration on the velocity of platelet aggregation. 116
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 106
Structural and funtional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib 103
Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease 94
Functional role of protease activated receptors in vascular biology 89
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. 89
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 89
Heparin induced thrombocytopenia: Position paper from the Italian Society on Thrombosis and Haemostasis (SISET) 88
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 86
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 86
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group 83
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 82
Mechanisms of platelet activation by thrombin: a short history 80
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? 80
MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY 78
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 78
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 78
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience 78
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 77
Hemophilia A and von Willebrand deficiency: therapeutic implications 77
Allosteric equilibria in the binding reaction of fibrinogen to platelets. 76
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 76
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 75
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 75
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 73
NETosis in arterial and venous thrombosis: a one size fits all mechanism? 72
Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives 69
Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency 69
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 68
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. 66
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 66
Thrombin interaction with platelet GpIB: role of the heparin binding domain. 65
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. 63
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 62
INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY BLOCKAGE OF NA+/H+ EXCHANGE. 61
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 60
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease 59
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 58
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 57
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia:Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 56
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 55
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 55
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 55
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome 52
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 51
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 50
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence 48
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders 45
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study 43
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 42
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome 40
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). 39
Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis 37
Extended coagulation profile of children with Long Covid: a prospective study 36
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study 32
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 29
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC 28
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 25
COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study 22
Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity 22
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study 9
Circulating Activated Platelets in Children With Long Covid: A Case-Controlled Preliminary Observation 8
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders 6
Association of human leucocyte antigen loci with vaccine-induced immune thrombotic thrombocytopenia: Potential role of the interaction between platelet factor 4-derived peptides and MHC-II 5
Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets 2
Totale 5.277
Categoria #
all - tutte 25.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020185 0 0 0 0 0 0 0 0 0 0 104 81
2020/2021579 29 68 12 64 70 73 46 21 50 44 90 12
2021/2022658 44 82 22 39 34 18 18 111 23 39 112 116
2022/20231.048 141 135 71 141 85 126 74 84 129 12 33 17
2023/2024657 19 161 27 34 28 70 48 16 12 26 52 164
2024/20251.040 24 32 113 64 65 46 42 49 172 133 300 0
Totale 5.277